Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Aducanumab BLA for Alzheimer Disease Submitted for FDA Review
Complementary, Alternative Medicine Use Increasing for MS
Novel Therapy for Alzheimer Disease Agitation Gets Breakthrough Designation
New Treatment Option for Dravet Syndrome Approved
FDA Approves DBS Neurostimulation System With Brain Signal Tracking
Pimavanserin sNDA Submitted for Dementia-Related Psychosis
Therapeutic Hookworm Explored for Relapsing Multiple Sclerosis
Higher Doses of Deutetrabenazine Examined in Patients With Huntington Disease-Associated Chorea
Uplizna Approved for Neuromyelitis Optica Spectrum Disorder
Gocovri sNDA Under Review for Off Episodes in Parkinson Disease
Antigen-Specific Therapy for Anti-MAG Neuropathy Gets Orphan Drug Status
New Oral Treatment for Relapsing Forms of MS Now Available
First Diagnostic Agent Approved to Image Tau Pathology in Patients Being Evaluated for Alzheimer Disease
Rebif Labeling Updated with Pregnancy, Lactation Data
Ofatumumab Bests Teriflunomide in Halting Disease Activity in MS Patients
Trial Assessing Efgartigimod for Myasthenia Gravis Meets Primary End Point
Vesicare LS Approved for Neurogenic Detrusor Overactivity
FDA Grants Fast Track Status to Arimoclomol for ALS
